Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Regenicin Inc. stock logo
RGIN
Regenicin
$0.00
$0.00
$0.00
N/AN/A50,000 shsN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$3.33
-0.2%
$2.96
$1.71
$8.60
$8.35M0.71934,993 shs13,472 shs
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$0.01
+6.6%
$0.01
$0.01
$0.11
$1.70M-1.551,440 shs6,000 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Regenicin Inc. stock logo
RGIN
Regenicin
0.00%0.00%0.00%0.00%-98.00%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.00%+3.26%+17.08%+58.33%-26.11%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
0.00%+5.07%+4.32%-14.71%-44.23%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Regenicin Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.5557 of 5 stars
3.54.00.00.00.01.70.0
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Regenicin Inc. stock logo
RGIN
Regenicin
0.00
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
3.00
Buy$28.00742.11% Upside
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RGIN, SINT, and UAHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/30/2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$30.00 ➝ $28.00
4/21/2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $30.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Regenicin Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.89M2.89N/AN/A$2.90 per share1.15
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Regenicin Inc. stock logo
RGIN
Regenicin
-$640KN/A0.00N/AN/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$11.02M-$50.56N/AN/A-483.85%-203.66%-104.76%8/4/2025 (Estimated)
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$240KN/A0.00N/AN/AN/AN/AN/A

Latest RGIN, SINT, and UAHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$0.71-$1.29-$0.58-$1.29$0.73 million$0.37 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Regenicin Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
$0.08551.72%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Regenicin Inc. stock logo
RGIN
Regenicin
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
3.44
3.25
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Regenicin Inc. stock logo
RGIN
Regenicin
0.01%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
N/A

Insider Ownership

CompanyInsider Ownership
Regenicin Inc. stock logo
RGIN
Regenicin
N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
0.01%
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
14.31%
CompanyEmployeesShares OutstandingFree FloatOptionable
Regenicin Inc. stock logo
RGIN
Regenicin
3165.77 millionN/ANot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
402.51 million2.51 millionNot Optionable
United American Healthcare Corp. stock logo
UAHC
United American Healthcare
31117.06 million100.31 millionNot Optionable

Recent News About These Companies

United American Healthcare CorpShs
HH Health System, United Healthcare reach agreement
Health Care Is on the Ballot Again

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Regenicin stock logo

Regenicin OTCMKTS:RGIN

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Sintx Technologies stock logo

Sintx Technologies NASDAQ:SINT

$3.32 -0.01 (-0.15%)
Closing price 07/3/2025 02:34 PM Eastern
Extended Trading
$3.25 -0.08 (-2.26%)
As of 08:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

United American Healthcare stock logo

United American Healthcare OTCMKTS:UAHC

$0.01 +0.00 (+6.62%)
As of 07/3/2025 12:38 PM Eastern

United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.